Matthew R. Skelton

2.6k total citations
70 papers, 2.1k citations indexed

About

Matthew R. Skelton is a scholar working on Cellular and Molecular Neuroscience, Cell Biology and Physiology. According to data from OpenAlex, Matthew R. Skelton has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 18 papers in Cell Biology and 14 papers in Physiology. Recurrent topics in Matthew R. Skelton's work include Neurotransmitter Receptor Influence on Behavior (21 papers), Neuroscience and Neuropharmacology Research (15 papers) and Muscle metabolism and nutrition (13 papers). Matthew R. Skelton is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (21 papers), Neuroscience and Neuropharmacology Research (15 papers) and Muscle metabolism and nutrition (13 papers). Matthew R. Skelton collaborates with scholars based in United States, Australia and France. Matthew R. Skelton's co-authors include Charles V. Vorhees, Michael T. Williams, Tori L. Schaefer, A Braun, Devon L. Graham, Curtis E. Grace, Nicole R. Herring, Gary A. Gudelsky, Robyn M. Amos‐Kroohs and Tracy M. Reed and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Matthew R. Skelton

68 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew R. Skelton United States	30	731	388	358	345	298	70	2.1k
Tori L. Schaefer United States	30	974 1.3×	589 1.5×	129 0.4×	165 0.5×	269 0.9×	63	2.2k
Jack W. Lipton United States	36	1.8k 2.5×	830 2.1×	717 2.0×	137 0.4×	373 1.3×	81	4.2k
A. William Tank United States	30	1.4k 1.9×	1.1k 2.8×	577 1.6×	271 0.8×	100 0.3×	57	3.1k
Ying‐Jui Ho Taiwan	28	759 1.0×	468 1.2×	390 1.1×	70 0.2×	53 0.2×	84	1.9k
Daisuke Ibi Japan	25	943 1.3×	949 2.4×	481 1.3×	98 0.3×	92 0.3×	54	2.6k
Maria da Graça Naffah‐Mazzacoratti Brazil	33	1.3k 1.7×	774 2.0×	449 1.3×	138 0.4×	440 1.5×	109	2.9k
Alicia Brusco Argentina	28	1.9k 2.6×	643 1.7×	358 1.0×	94 0.3×	406 1.4×	87	3.5k
Maria Teresa Viscomi Italy	31	1.1k 1.5×	705 1.8×	353 1.0×	96 0.3×	96 0.3×	79	2.8k
Joyce L.W. Yau United Kingdom	33	538 0.7×	541 1.4×	356 1.0×	87 0.3×	426 1.4×	59	3.3k
Emilio Fernández‐Espejo Spain	27	1.3k 1.8×	533 1.4×	387 1.1×	43 0.1×	88 0.3×	89	2.4k

Countries citing papers authored by Matthew R. Skelton

Since Specialization

Citations

This map shows the geographic impact of Matthew R. Skelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Skelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Skelton more than expected).

Fields of papers citing papers by Matthew R. Skelton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Skelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Skelton. The network helps show where Matthew R. Skelton may publish in the future.

Co-authorship network of co-authors of Matthew R. Skelton

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Skelton. A scholar is included among the top collaborators of Matthew R. Skelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Skelton. Matthew R. Skelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Disdier, Clémence, Sébastien Goutal, Anne-Cécile Guyot, et al.. (2024). Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model. Neurobiology of Disease. 202. 106720–106720. 1 indexed citations

Harati, Rania, Clémence Disdier, Anne-Cécile Guyot, et al.. (2023). Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency. eLife. 12. 4 indexed citations

Lundgren, Kerstin H., et al.. (2019). Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice. Journal of Molecular Neuroscience. 70(1). 102–111. 7 indexed citations

Perna, Marla K., et al.. (2019). Deletion of the creatine transporter gene in neonatal, but not adult, mice leads to cognitive deficits. Journal of Inherited Metabolic Disease. 42(5). 966–974. 14 indexed citations

Williams, Michael T., et al.. (2018). Cognitive deficits and increases in creatine precursors in a brain‐specific knockout of the creatine transporter gene Slc6a8. Genes Brain & Behavior. 17(6). e12461–e12461. 22 indexed citations

Skelton, Matthew R., et al.. (2018). Intranasal carnosine attenuates transcriptomic alterations and improves mitochondrial function in the Thy1-aSyn mouse model of Parkinson's disease. Molecular Genetics and Metabolism. 125(3). 305–313. 20 indexed citations

Perna, Marla K., et al.. (2016). Creatine transporter deficiency leads to increased whole body and cellular metabolism. Amino Acids. 48(8). 2057–2065. 29 indexed citations

Williams, Michael T., et al.. (2014). Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine. Toxicology Reports. 1. 699–706. 2 indexed citations

Braun, A, Robyn M. Amos‐Kroohs, Arnold Gutierrez, et al.. (2014). Dopamine depletion in either the dorsomedial or dorsolateral striatum impairs egocentric Cincinnati water maze performance while sparing allocentric Morris water maze learning. Neurobiology of Learning and Memory. 118. 55–63. 44 indexed citations

10.

Williams, Michael T., et al.. (2013). Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits. Journal of Inherited Metabolic Disease. 37(1). 63–68. 23 indexed citations

11.

Vorhees, Charles V., Devon L. Graham, A Braun, et al.. (2012). Prenatal immune challenge in rats: Altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route‐based learning as a function of maternal body weight gain after prenatal exposure to poly IC. Synapse. 66(8). 725–737. 50 indexed citations

12.

Wong, Ann Chi Yan, et al.. (2012). Expression and distribution of creatine transporter and creatine kinase (brain isoform) in developing and mature rat cochlear tissues. Histochemistry and Cell Biology. 137(5). 599–613. 10 indexed citations

13.

Sun, Yunpeng, Huimin Ran, Kazuyuki Kitatani, et al.. (2009). Specific saposin C deficiency: CNS impairment and acid -glucosidase effects in the mouse. Human Molecular Genetics. 19(4). 634–647. 31 indexed citations

14.

Vorhees, Charles V., Tori L. Schaefer, Matthew R. Skelton, et al.. (2009). (+/–)3,4-Methylenedioxymethamphetamine (MDMA) Dose-Dependently Impairs Spatial Learning in the Morris Water Maze after Exposure of Rats to Different Five-Day Intervals from Birth to Postnatal Day Twenty. Developmental Neuroscience. 31(1-2). 107–120. 36 indexed citations

15.

Skelton, Matthew R., Tori L. Schaefer, Nicole R. Herring, et al.. (2009). Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (±)-3,4-methylenedioxymethamphetamine (ecstasy) in rats. Psychopharmacology. 204(2). 287–297. 25 indexed citations

16.

Skelton, Matthew R., Jessica Able, Curtis E. Grace, et al.. (2008). (±)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: A comparison of single vs once per week treatment for 5 weeks. Neuropharmacology. 55(7). 1121–1130. 25 indexed citations

17.

Vorhees, Charles V., Matthew R. Skelton, Curtis E. Grace, et al.. (2008). Effects of (+)‐methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. International Journal of Developmental Neuroscience. 27(3). 289–298. 38 indexed citations

18.

Schaefer, Tori L., Matthew R. Skelton, Nicole R. Herring, et al.. (2007). Short‐ and long‐term effects of (+)‐methamphetamine and (±)‐3,4‐methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. Journal of Neurochemistry. 104(6). 1674–1685. 42 indexed citations

19.

Vorhees, Charles V., Matthew R. Skelton, & Michael T. Williams. (2007). Age-dependent effects of neonatal methamphetamine exposure on spatial learning. Behavioural Pharmacology. 18(5-6). 549–562. 36 indexed citations

20.

Skelton, Matthew R., et al.. (2003). Protein tyrosine phosphatase alpha (PTPα) knockout mice show deficits in Morris water maze learning, decreased locomotor activity, and decreases in anxiety. Brain Research. 984(1-2). 1–10. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact